13F Data
13F filer · CIK 1274403

ARCH Venture Management, LLC

CHICAGO, IL · filing since Q4 2018 · last filing Aug 14, 2026
Reported value
$1.1B
+$423.2M vs prior
Positions
12
New / sold out
3 / 1
Added / reduced
0 / 1
Turnover
0.5%
buys $318.9M · sells $4.3M
Top-10 weight
99.3%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewPARABILIS MEDICINES INC+6,412,780–+$175.5M
NewSEAPORT THERAPEUTICS INC+6,294,951–+$136.6M
NewBOUNDLESS BIO INC+2,694,095–+$6.7M

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedVIR BIOTECHNOLOGY INC-222,500-1.7%$-2.3M
Sold outQ32 BIO INC-320,482-100.0%$-2.1M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2018: $100.0MQ1 2019: $103.5MQ2 2019: $96.6MQ3 2019: $91.4MQ4 2019: $76.7MQ1 2020: $59.2MQ2 2020: $29.7MQ3 2020: $20.0MQ4 2021: $945.3MQ1 2022: $699.8MQ2 2022: $820.6MQ3 2022: $771.4MQ4 2022: $390.4MQ1 2023: $207.2MQ2 2023: $162.0MQ3 2023: $154.0MQ4 2023: $163.5MQ1 2024: $80.3MQ2 2024: $266.0MQ3 2024: $260.6MQ4 2024: $230.2MQ1 2025: $206.2MQ2 2025: $299.1MQ3 2025: $492.4MQ4 2025: $651.7MQ1 2026: $677.1MQ2 2026: $1.1B
Q4 2018Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1PARABILIS MEDICINES INCCOM6,412,780$175.5M15.95%
2BEAM THERAPEUTICS INCCOM4,540,132$155.8M14.16%
3RAPPORT THERAPEUTICS INCCOM3,728,738$155.4M14.12%
4SEAPORT THERAPEUTICS INCCOMMON STOCK6,294,951$136.6M12.42%
5ERASCA INCCOM7,091,557$129.9M11.81%
6VIR BIOTECHNOLOGY INCCOM12,694,163$129.4M11.76%
7MAZE THERAPEUTICS INCCOM4,120,053$123.0M11.18%
8LYELL IMMUNOPHARMA INCCOM NEW3,247,162$45.5M4.14%
9GENERATE BIOMEDICINES INCCOM SHS1,944,426$32.8M2.98%
1010X GENOMICS INCCL A COM217,834$8.4M0.76%
2 more rows. Subscribe for $29/month to see every row, download the data and use the API.